NanoString Technologies (NSTG) – Globe Newswire
-
Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announce
-
Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announce
-
CareDx Adds HistoMap To Testing Portfolio
-
NanoString to Present at the 2019 Morgan Stanley Global Healthcare Conference
-
NanoString to Present at the Baird 2019 Global Healthcare Conference
-
New Publication Demonstrates First Use of NanoString’s GeoMx Digital Spatial Profiler in Neuroscience
-
NanoString Technologies Releases Operating Results for Second Quarter of 2019
-
NanoString Technologies and Mayo Clinic Laboratories Enter Joint Development Agreement to Develop Novel Assays
Back to NSTG Stock Lookup